Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-083756
Filing Date
2020-07-15
Accepted
2020-07-15 16:50:49
Documents
34
Period of Report
2020-05-31

Document Format Files

Seq Description Document Type Size
1 10-Q a20-24282_110q.htm 10-Q 328027
2 EX-31.1 a20-24282_1ex31d1.htm EX-31.1 10977
3 EX-31.2 a20-24282_1ex31d2.htm EX-31.2 10834
4 EX-32.1 a20-24282_1ex32d1.htm EX-32.1 6326
5 EX-32.2 a20-24282_1ex32d2.htm EX-32.2 6301
  Complete submission text file 0001104659-20-083756.txt   1273636

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bzyr-20200531.xml EX-101.INS 143452
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bzyr-20200531.xsd EX-101.SCH 16294
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bzyr-20200531_cal.xml EX-101.CAL 17930
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bzyr-20200531_lab.xml EX-101.LAB 146442
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bzyr-20200531_pre.xml EX-101.PRE 90919
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bzyr-20200531_def.xml EX-101.DEF 35700
Mailing Address 9432 KATY FREEWAY HOUSTON TX 77055
Business Address 12000 RICHMOND AVE HOUSTON TX 77082 (713) 335-5697
BURZYNSKI RESEARCH INSTITUTE INC (Filer) CIK: 0000724445 (see all company filings)

EIN.: 760136810 | State of Incorp.: DE | Fiscal Year End: 0229
Type: 10-Q | Act: 34 | File No.: 000-23425 | Film No.: 201029542
SIC: 2835 In Vitro & In Vivo Diagnostic Substances